Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.

ABSTRACT

BACKGROUND: There is an increased risk of arterial events including major adverse cardiovascular events (MACE) and major adverse limb events (MALE) after venous thromboembolism (VTE). However, their risk factors remain little explored. METHODS: We aimed to determine the risk factors for MACE (acute coronary syndrome/stroke/cardiovascular death) and MALE (limb ischemia/critical limb ischemia/non-traumatic amputation/any limb revascularization) after VTE. Competing risk models (Fine-Gray) were used in a multicenter prospective cohort of 4,940 patients (mean age 64.6 years and median follow-up 64 months). RESULTS: MACE occurred in 17.3% of participants (2.35% per patient-years) and MALE in 1.7% (0.27% per patient-years). In multivariable analysis, the identified risk factors for MACE were the age of 50 to 65 years (vs. <50 years, hazard ratio [HR] 2.00, 95% confidence interval [CI] 1.38-2.91), age >65 years (vs. <50 years, HR 4.85, 95% CI 3.35-7.02), pulmonary embolism + deep vein thrombosis (DVT) (vs. isolated-DVT, HR 1.25, 95% CI 1.02-1.55), unprovoked-VTE (vs. transient risk factor associated-VTE, HR 1.29, 95% CI 1.04-1.59), current tobacco use (vs. never, HR 1.45, 95% CI 1.07-1.98), hypertension (HR 1.61, 95% CI 1.30-1.98), past history of symptomatic atherosclerosis (HR 1.52, 95% CI 1.17-1.98), heart failure (HR 1.71, 95% CI 1.21-2.42), atrial fibrillation (HR 1.55, 95% CI 1.15-2.08), and vena cava filter insertion (HR 1.46, 95% CI 1.03-2.08). The identified risk factors for MALE were the age of 50-65 years (vs. <50 years, HR 3.49, 95% CI 1.26-9.65) and atrial fibrillation (HR 2.37, 95% CI 1.15-4.89). CONCLUSIONS: Risk factors for MACE and MALE after VTE included some traditional cardiovascular risk factors, patient's comorbidities, and some characteristics of VTE.